FAQs 

Given the pioneering nature of Mane Biotech's solution, it is normal to have questions regarding our work.

  • What causes hair loss? 

Hair loss can be caused by different factors, for example, as a normal result of ageing, hormonal changes, stress, injury or from medical conditions.

  • What kind of hair loss does Mane Biotech's technology aim to resolve? 

Mane Biotech is developing technology to combat common hair loss, scientifically termed as Androgenetic Alopecia. Common hair loss affects the majority of hair loss sufferers, with an estimated 90% of men and 30-40% of women experiencing hair loss. Mane Biotech's technology not only stops hair loss but more importantly reactivates physiological hair growth, which is normally impaired in people with common hair loss.

  • Are the technology and approach safe? 

Yes! Mane Biotech's approach uses natural stimuli to kick-start hair growth. No chemicals, no drugs, no oil, no harmful or invasive  procedures. Moreover, no relevant side effects have been reported to date.

  • Are the technology and approach effective? What science is there to back it up? 

Yes! Mane Biotech validated the ability of its approach to kick-start hair regrowth via hair follicle stem cell activation and expansion, which are key steps in hair growth. These processes have been further demonstrated in more complex biological systems. 

​​

  • When will this technology be available on the market? 

Despite the disruptions caused by the COVID-19 pandemic, Mane Biotech aims to bring its flagship product to market in Winter 2022. Sign up to the mailing list and stay informed!